Athira Pharma logo

Athira Pharma

ATHA | NASDAQ
Chart Builder DCF Calculator
$6.75
-$0.44 (-6.12%)
At close: Jan 09, 2026, 04:00 PM ET
-6.12%

Rating

Updated: Sep 22, 2026
24
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $26.62M
1D Range
6.61 7.35
52W Range
2.20 8.36

Valuation (TTM)

PE -0.29
PB 0.79
EV/EBITDA 1.18

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $13.33
Loading financial charts...

Profile

Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function ...

Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Sep 18, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.